Literature DB >> 15814978

Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study.

Kei Kasahara1, Koichi Maeda, Keiichi Mikasa, Kenji Uno, Ken Takahashi, Mitsuru Konishi, Eiichiro Yoshimoto, Koichi Murakawa, Eiji Kita, Hiroshi Kimura.   

Abstract

Large-scale surveillance studies using molecular techniques such as pulsed-field gel electrophoresis (PFGE) have revealed that the spread of antibiotic-resistant pneumococci is due to clonal spread. However, in Japan, surveillance studies using such molecular techniques have never been done. Therefore, we conducted a pilot surveillance study to elucidate the present situation in Japan. Among the 145 isolates examined, the most prevalent serotype was type 19F (20%), for which most isolates were not susceptible to penicillin (86.2%) but were positive for the mef(A)/mef(E) gene (89.7%). The secondmost prevalent was serotype 3 (16.6%), for which most isolates were susceptible to penicillin (87.5%) and positive for the erm(B) gene (91.7%). PFGE analysis showed that both serotypes consisted mainly of clonally identical or related isolates and, in particular, 38% of the type 19F isolates were indistinguishable from or closely related to the Taiwan 19F-14 clone. In addition, some of the Japanese type 23F isolates with the erm(B) gene were indistinguishable from or related to the Taiwan 23F-15 clone as analyzed by PFGE. Based on the results of our pilot study performed in a single institution, it is likely that international antibiotic-resistant clones have already spread in Japan; therefore, a nationwide surveillance study should be urgently conducted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814978      PMCID: PMC1081314          DOI: 10.1128/JCM.43.4.1640-1645.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates.

Authors:  K Overweg; D Bogaert; M Sluijter; J Yother; J Dankert; R de Groot; P W Hermans
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000.

Authors:  S S Richter; K P Heilmann; S L Coffman; H K Huynh; A B Brueggemann; M A Pfaller; G V Doern
Journal:  Clin Infect Dis       Date:  2001-12-17       Impact factor: 9.079

3.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment.

Authors:  K Gay; W Baughman; Y Miller; D Jackson; C G Whitney; A Schuchat; M M Farley; F Tenover; D S Stephens
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

5.  Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.

Authors:  Bernard Beall; M Catherine McEllistrem; Robert E Gertz; David J Boxrud; John M Besser; Lee H Harrison; James H Jorgensen; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226

Review 6.  Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia.

Authors:  Joseph P Lynch III; Fernando J Martinez
Journal:  Clin Infect Dis       Date:  2002-03-01       Impact factor: 9.079

7.  Macrolide resistance in Streptococcus pneumoniae in Hong Kong.

Authors:  M Ip; D J Lyon; R W Yung; C Chan; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

8.  The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

Authors:  W P Hausdorff; J Bryant; C Kloek; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

9.  Levofloxacin failure in a patient with pneumococcal pneumonia.

Authors:  P E Empey; H R Jennings; A C Thornton; R P Rapp; M E Evans
Journal:  Ann Pharmacother       Date:  2001-06       Impact factor: 3.154

10.  Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan.

Authors:  Shin-Ichi Yokota; Kiyoshi Sato; Osamu Kuwahara; Satoshi Habadera; Naoyuki Tsukamoto; Hironori Ohuchi; Hirotsugu Akizawa; Tetsuo Himi; Nobuhiro Fujii
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

View more
  9 in total

1.  Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.

Authors:  Yasuki Yasuda; Kei Kasahara; Fumiko Mizuno; Kazuyuki Nishi; Keiichi Mikasa; Eiji Kita
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

2.  Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan.

Authors:  L Qin; H Watanabe; H Yoshimine; H Guio; K Watanabe; K Kawakami; A Iwagaki; H Nagai; H Goto; T Kuriyama; Y Fukuchi; T Matsushima; S Kudoh; K Shimada; K Matsumoto; T Nagatake; T Mizota; K Oishi
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

3.  An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.

Authors:  Kedibone M Mothibeli; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Peter Adrian; Shabir A Madhi; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

4.  Antimicrobial susceptibility and genetic characteristics of Streptococcus pneumoniae isolates indicating possible nosocomial transmission routes in a community hospital in Japan.

Authors:  Liang Qin; Hironori Masaki; Kiwao Watanabe; Akitsugu Furumoto; Hiroshi Watanabe
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

5.  Pneumococcal surface protein A family types of Streptococcus pneumoniae from community-acquired pneumonia patients in Japan.

Authors:  Y Ito; M Osawa; R Isozumi; S Imai; I Ito; T Hirai; T Ishida; S Ichiyama; M Mishima
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

6.  Genotypes and related factors reflecting macrolide resistance in pneumococcal pneumonia infections in Japan.

Authors:  Rie Isozumi; Yutaka Ito; Tadashi Ishida; Makoto Osawa; Toyohiro Hirai; Isao Ito; Ko Maniwa; Michio Hayashi; Hitoshi Kagioka; Masataka Hirabayashi; Koichi Onari; Hiromi Tomioka; Keisuke Tomii; Iwao Gohma; Seiichiro Imai; Shunji Takakura; Yoshitsugu Iinuma; Satoshi Ichiyama; Michiaki Mishima
Journal:  J Clin Microbiol       Date:  2007-03-07       Impact factor: 5.948

7.  High carriage rate of high-level penicillin-resistant Streptococcus pneumoniae in a Taiwan kindergarten associated with a case of pneumococcal meningitis.

Authors:  Tsai-Ling Lauderdale; Wei Yang Lee; Ming Fang Cheng; I Fei Huang; Yu Chen Lin; Kai Sheng Hseih; I-Wen Huang; Christine C Chiou
Journal:  BMC Infect Dis       Date:  2005-11-01       Impact factor: 3.090

Review 8.  Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review.

Authors:  Setareh Mamishi; Sepideh Moradkhani; Shima Mahmoudi; Reihaneh Hosseinpour-Sadeghi; Babak Pourakbari
Journal:  Iran J Microbiol       Date:  2014-08

9.  Virulence factors and antibiotic resistance properties of Streptococcus species isolated from hospital cockroaches.

Authors:  Mohammad Chehelgerdi; Reza Ranjbar
Journal:  3 Biotech       Date:  2021-06-10       Impact factor: 2.893

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.